NALONAZE

Welcome to the Brand page for “NALONAZE”, which is offered here for Pharmaceutical and drug preparations for use in treatment of opioid overdose and addiction; medicinal preparations for use in treatment of opioid overdose and addiction; pharmaceutical and drug preparations for the treatment of substance use disorders, addiction, and overdose; medicinal preparations for the treatment of substance use disorders, addiction, and overdose; pharmaceutical preparations, opioid antagonists; pharmaceutical preparations, pharmaceuticals which contain the compound naloxone for use in the treatment of complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics; pharmaceutical and drug preparations for use in complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics;.

Its status is currently believed to be active. Its class is unavailable. “NALONAZE” is believed to be currently owned by “AMPHASTAR PHARMACEUTICALS, INC.”